Riskpilot← Back to searchSign inGet full accessAquaporin Membrane Proteins ApS
APSDissolvedCVR 37407976Nymøllevej 78Manufacture of pharmaceutical preparations · NACE 2120Est. 20167 employees
Revenue 2021
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2021
—
7 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | DKK 0 | — |
| Equity | — | — |
| Employees | 7 | — |
Legal name
Aquaporin Membrane Proteins ApS
CVR number
37407976
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
27. januar 2016
Share capital
DKK 128.206
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening.
Address
Nymøllevej 78
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 0 | — | — | — | — |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | — | — | — | — |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | — | — | — | — |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 5.699 | — | — | — | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 14.889 | 0 | 0 | 0 | 0 |
| Equity | 12.309 | — | — | — | — |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.579 | 0 | 0 | 0 | 0 |
| Total debt | 2.579 | 0 | 0 | 0 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172021
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20172021
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20172021
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
PH Management | Management | 2018 – 2022 |
KJ Management | Management | 2022 – 2022 |
TH Chief Executive Officer | Chief Executive Officer | 2016 – 2018 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Chairman | 2016 – 2018 | |
| Chairman | 2016 – 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 10–14.99% | 10–14.99% | 2016 | |
| Company | 100% | 100% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2016 | |
| Individual | 5–9.99% | 5–9.99% | 2016 | |
| Individual | 5–9.99% | 5–9.99% | 2016 | |
| Individual | 5–9.99% | 5–9.99% | 2016 | |
| Individual | 33.33–49.99% | 33.33% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aquaporin Membrane Proteins ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Holme Jensen | Management | 0 companies |
| Klaus Juhl Wulff | Management | 0 companies |
| Torsten Høybye Bak Regueira | Chief Executive Officer | 0 companies |
| Bo Løkke Karmark | Deputy Chairman | 0 companies |
| Søren Bjørn Hansen | Chairman | 0 companies |